BioSpace News Archive

BioMarin Pharmaceutical Inc., announced that Jean-Jacques Bienaimé, Chairman and Chief Executive Officer, will present at the BofA Securities Healthcare Conference on May 12 at 8:40am PT/11:40am ET in Las Vegas.

NLS Pharmaceutics Ltd. announces that 90% of the 60 patients required to complete its Phase 2a clinical trial for Quilience have been randomized and the Company continues to expect to report final results from this ground-breaking trial by mid-Q3 2022.

IBN (“InvestorBrandNetwork”), an innovative content distributor and multifaceted communications organization with 50+ brands including BioMedWire (“BMW”), is pleased to announce that it will be collaborating with Hanson Wade as an official media sponsor for the upcoming 2nd Annual Gene Therapy Patient Engagement Summit.

Stevanato Group S.p.A. (NYSE: STVN), a global provider of drug containment, drug delivery and diagnostic solutions to the pharmaceutical, biotechnology and life sciences industries, has signed an exclusive agreement with leading medical device developer and manufacturer Owen Mumford Ltd. for its Aidaptus® auto-injector.

Jade Diabetes releases world first voice-based insulin dosing for diabetes that turns the labor-intensive task of logging blood sugars, carbohydrates, insulin and exercise into a natural conversation.

Cristal Therapeutics, a Dutch pharmaceutical company developing tailored nanomedicines for the treatment of cancer and other diseases with high unmet patient need, today announced the publication of the results of the clinical PICCOLO study in the peer-reviewed journal, Advanced Materials1.

Paradigm4 has today unveiled REVEALTM: Proteomics, the newest use case specific app powered by the Paradigm4 FLASHTM high-performance bioinformatics platform.

Curiox Biosystems, Inc., a global leader in biological sample preparation for life science research, announced that it has named Don O’Neil to the newly created position of Chief Commercialization Officer.

The National Academy of Sciences has elected The Feinstein Institutes for Medical Research’s Betty Diamond, MD, in recognition of her breakthrough achievements in molecular medicine and original research.

Onconova Therapeutics, Inc., a clinical-stage biopharmaceutical company focused on discovering and developing novel products for patients with cancer, announced that the Company intends to release its first quarter 2022 financial results on Wednesday, May 11, 2022.